WA
NVAX icon

WealthTrust-Arizona’s Novavax NVAX Stock Holding History

WealthTrust-Arizona’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8
Closed -$1K – 654
2014
Q3 		$1K Hold
8
– – ﹤0.01% 616
2014
Q2 		$1K Hold
8
– – ﹤0.01% 605
2014
Q1 		$1K Buy
+8
New +$894 ﹤0.01% 649

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WealthTrust-Arizona's NVAX Position: Q4 2014 in Review

WealthTrust-Arizona sold out of Novavax (NVAX) in Q4 2014, closing a stake of 8 shares — an estimated $1K sold.

WealthTrust-Arizona first reported a position in NVAX in Q1 2014 and held it in 3 quarters. The position peaked at $1K in Q3 2014. 153 funds tracked by Wall St. Rank hold NVAX as of Q4 2014.

  • WealthTrust-Arizona reported no remaining Novavax position as of Q4 2014 after selling out during the quarter.
  • WealthTrust-Arizona sold 8 Novavax shares in Q4 2014, an estimated $1K.
  • WealthTrust-Arizona first reported a position in Novavax in Q1 2014 and held it in 3 quarters.
  • WealthTrust-Arizona's Novavax position peaked at $1K in Q3 2014.
  • 153 funds tracked by Wall St. Rank held Novavax as of Q4 2014.

Based on WealthTrust-Arizona's 13F filing for Q4 2014, filed 22 Jan 2015.